Key Highlights

  • Marvell Technology (NASDAQ:MRVL) closed at USD 159.80 in the November 4, 2026 session, down 7.08%, on 46.57 million shares, about USD 7.4 billion of stock, fifteenth on the most-active screen by traded value.
  • Relative Volume was 1.63 as the stock extended a multi-day slide that began when Marvell agreed on November 2 to buy Lumentum in an all-stock deal with an implied Enterprise value of USD 115 billion.
  • Lumentum holders are to receive 4.5 Marvell shares per share, about USD 1,132 at announcement and a 23.9% premium, and would own about 33% of the combined company.
  • The stock fell a further 16.43% to USD 133.55 on November 5 as the semiconductor index dropped about 12%.

Why Marvell Kept Falling

The deal is the main reason for the heavy trading. On November 2, Marvell agreed to combine with Lumentum, a maker of lasers and optical components used to connect AI servers, in a transaction that would create a large supplier of AI networking and optical connectivity. The companies expect more than USD 1 billion of annual cost savings and plan to close in the first half of 2028. Investors focused on the cost. Because the deal is paid entirely in shares, Marvell holders face significant dilution, with Lumentum owners set to hold about a third of the combined company. Several Brokers downgraded the stock and cut price targets, and a company executive sold 10,000 shares on the day of the announcement. On November 4, the post-election rotation out of AI chips added to the pressure. Relative volume of 1.63 confirms that the repositioning was heavy, as Merger arbitrage funds and long-term holders adjusted their exposure.

The Deal Terms and the Long Timeline

The exchange ratio is fixed at 4.5 Marvell shares for each Lumentum share, with no collar, so the value Lumentum holders receive moves with Marvell's share price. At announcement the offer was worth about USD 1,132 per share, a 23.9% premium to Lumentum's unaffected close on October 28. Closing is expected in the first half of 2028, with extensions possible to August 2028, because the deal needs approvals in several countries, including China. Marvell would owe Lumentum a USD 3.2 billion termination fee if the deal fails in certain circumstances. The long timeline leaves both companies exposed to the AI spending cycle, which turned sharply this week. The screen showed a trailing P/E of 52.62 on diluted EPS of USD 3.04 and a Market Value of about USD 140 billion. For Marvell holders, the long gap before closing means the share price will carry both the cost of the deal and the swings of the AI cycle for many months.

Risks and What to Watch

The risks are regulatory delay or rejection, dilution, integration of two large businesses and a slower AI buildout during a two-year approval process. On November 5, Marvell fell 16.43% to USD 133.55, and on November 6 chip stocks rebounded with the Nasdaq after a strong jobs report. Investors should watch filings with competition authorities, any change to the deal terms, quarterly results from both companies and orders for optical components from large cloud customers. The gap between Lumentum's share price and the value implied by the exchange ratio is a useful gauge of how much doubt the market places on completion.

Where Things Stand

Marvell was among the most active stocks on November 4 because investors were still digesting a large all-stock deal for Lumentum when the post-election rotation out of AI chips hit. The 7.08% fall became a 16.43% drop the next day. The strategic logic is clear, but dilution, a long approval process and a weaker AI tape have weighed on the shares. Regulatory progress will set the tone.